These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18346509)

  • 1. The placebo response in studies of acute migraine.
    Fernandes R; Ferreira JJ; Sampaio C
    J Pediatr; 2008 Apr; 152(4):527-33, 533.e1. PubMed ID: 18346509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls.
    Loder E; Goldstein R; Biondi D
    Cephalalgia; 2005 Feb; 25(2):124-31. PubMed ID: 15658949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.
    Evers S; Marziniak M; Frese A; Gralow I
    Cephalalgia; 2009 Apr; 29(4):436-44. PubMed ID: 19170687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo response in the prophylaxis of migraine: a meta-analysis.
    Macedo A; Baños JE; Farré M
    Eur J Pain; 2008 Jan; 12(1):68-75. PubMed ID: 17451980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
    Aurora SK; Rozen TD; Kori SH; Shrewsbury SB
    Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
    Dahlöf CG; Pascual J; Dodick DW; Dowson AJ
    Cephalalgia; 2006 Apr; 26(4):400-8. PubMed ID: 16556240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
    Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B
    Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults.
    Ho TW; Fan X; Rodgers A; Lines CR; Winner P; Shapiro RE
    Cephalalgia; 2009 Jul; 29(7):711-8. PubMed ID: 19210513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute treatment of paediatric migraine: a meta-analysis of efficacy.
    Silver S; Gano D; Gerretsen P
    J Paediatr Child Health; 2008 Jan; 44(1-2):3-9. PubMed ID: 17854415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of placebo in headache research.
    Diener HC; Schorn CF; Bingel U; Dodick DW
    Cephalalgia; 2008 Oct; 28(10):1003-11. PubMed ID: 18727647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
    Mannix LK; Loder E; Nett R; Mueller L; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
    Cephalalgia; 2007 May; 27(5):414-21. PubMed ID: 17448179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo effects in treating migraine and other headaches.
    Diener HC
    Curr Opin Investig Drugs; 2010 Jul; 11(7):735-9. PubMed ID: 20597189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
    Goadsby PJ
    Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
    Cady RK; Freitag FG; Mathew NT; Elkind AH; Mao L; Fisher AC; Biondi DM; Finlayson G; Greenberg SJ; Hulihan JF
    Headache; 2009 Mar; 49(3):350-63. PubMed ID: 19220503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis.
    Ho TW; Rodgers A; Bigal ME
    Headache; 2009 Mar; 49(3):395-403. PubMed ID: 19222588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine treatment and placebo effect.
    Speciali JG; Peres M; Bigal ME
    Expert Rev Neurother; 2010 Mar; 10(3):413-9. PubMed ID: 20187863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravenous valproic acid for acute migraine.
    Frazee LA; Foraker KC
    Ann Pharmacother; 2008 Mar; 42(3):403-7. PubMed ID: 18303140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.